BPMC
Blueprint Medicines
BPMC
BPMC
Delisted
BPMC was delisted on the 17th of July, 2025.
319 hedge funds and large institutions have $6.04B invested in Blueprint Medicines in 2024 Q3 according to their latest regulatory filings, with 55 funds opening new positions, 141 increasing their positions, 83 reducing their positions, and 39 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
2.81% less ownership
Funds ownership: 105.94% → 103.12% (-2.8%)
15% less capital invested
Capital invested by funds: $7.15B → $6.04B (-$1.11B)
25% less funds holding in top 10
Funds holding in top 10: 8 → 6 (-2)
Holders
319
Holding in Top 10
6
Calls
$218M
Puts
$124M
Top Buyers
| 1 | +$72.4M | |
| 2 | +$46.9M | |
| 3 | +$38.3M | |
| 4 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
+$30.4M |
| 5 |
ClearBridge Investments
New York
|
+$25.9M |
Top Sellers
| 1 | -$168M | |
| 2 | -$92M | |
| 3 | -$54.2M | |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
-$54.1M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$48.3M |